KABOOM action strips, Sexual Performance Strips, packaged in 6.4oz box 12 strips per box, Nutrology USA LLC
Published November 25, 2015 · Recall initiated: August 6, 2015
Summary
FDA records drug Class I recall D-0297-2016, published November 25, 2015 and initiated August 6, 2015. Recalling firm: Blue Square Market, Inc.; Status: Terminated; Reported quantity: 132 boxes; Lot: all lots. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without An Approved NDA/ANDA: presence of undeclared Sulfoaildenafil.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Blue Square Market, Inc.
- Distributor
- Nationwide
- Lot
- all lots
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVoriconazole Solution (1%(10 mg/mL), 15 mL dropper bottle; For Topical Ophthalmic Use, Rx only, Compounded byNovember 25, 2015
- FDAL-Tryptophan Injectable, 30mg/mL, 30mL vial, Rx only, Downing Labs, LLC 4001 McEwen Rd, Suite 110, Dallas TX,November 25, 2015
- FDAVancomycin Ophthalmic PF 0.5 mL (5 mg/0.5 mL (10 mg/mL), 1 mL syringe, For Topical Ophthalmic Use, Rx only,November 25, 2015
- FDAAcetyl-L-Carnitine Injectable, 100mg/mL, 30mL vial, L-Carnitine Injection 500mg/mL, 30mL vial, Rx only,November 25, 2015
- FDATropicamide 0.5%/ Phenylephrine 5%, 2 mL Dropper Bottle For Topical Ophthalmic Use, Rx only, Compounded by USNovember 25, 2015
- FDARiboflavin-5-Phosphate Injectable,10mg/mL, 10mL vial, Rx only, Downing Labs, LLC 4001 McEwen Rd, Suite 110,November 25, 2015
Questions about this recall
Was KABOOM action strips, Sexual Performance Strips, packaged in 6.4oz box 12 strips per box, Nutrology USA LLC recalled?
Yes. FDA published recall D-0297-2016 on November 25, 2015. Reported hazard: Marketed Without An Approved NDA/ANDA: presence of undeclared Sulfoaildenafil.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release